About
MEDIAIPLUS is a Pangyo, South Korea-based clinical trial intelligence company combining its MediC global trial data platform, the AI-driven FiCRO CRO-matching service and AI-assisted protocol drafting to help pharma and biotech sponsors cut trial preparation time and cost.
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- MEDIAIPLUS
MEDIAIPLUS is a Pangyo, South Korea-based clinical trial intelligence company combining its MediC global trial data platform, the AI-driven FiCRO CRO-matching service and AI-assisted protocol drafting to help pharma and biotech sponsors cut trial preparation time and cost.
—
United States
BusinessLatest roundTotal raisedDate- PhaseV
Uses machine learning to help pharmaceutical companies design and analyze adaptive clinical trials
Series A · $65M · 2025-05
$65M - Mandolin
AI matching of patients with clinical trials and cutting-edge therapies
Undisclosed · $40M · 2025-06
$40M - Layer Health
Uses AI to analyze unstructured data in patient records, helping providers and researchers with quality reporting and clinical research
Series A · $25M · 2025-03
$25M
China
BusinessLatest roundTotal raisedDateEurope
BusinessLatest roundTotal raisedDate- Qureight
3D deep learning analysis of lung/heart scans, providing imaging CRO services, AI biomarkers and precision endpoints for pharma trials
Series B · $31M · 2026-07
$31M - Perceptic
AI agents that connect research, clinical and operational data for pharma in drug discovery, trial design and asset evaluation
Seed · $12M · 2026-05
$12M - Iomed
NLP-based data extraction from medical records, clinical trials and patient surveys
Series A · $11M · 2023-09
$11M
Other / unspecified
BusinessLatest roundTotal raisedDate- Reliant AI
Uses generative AI to help biopharma companies organize and analyze data for clinical trials or scientific publications
Seed · $11M · 2024-08
$11M - Sarborg
AI agents that help pharmaceutical companies optimize drug repurposing and clinical trial decisions
Seed · $10M · 2025-08
$10M - Scopia Surgical
AI surgical navigation software combining real-time spatial intelligence and patient-specific digital twins for robot-assisted and minimally invasive soft-tissue surgery
Pre-Seed · $3M · 2026-09
$3M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.